ApaI, BsmI, FokI and TaqI polymorphisms in the vitamin D receptor (VDR) gene and the risk of psoriasis: A meta-analysis

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 6, 2013, Pages 739-746

  Liu, J L ^a   Zhang, S Q ^b,c   Zeng, H M ^d  

^a Hainan Nongken General Hospital   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Ministry of National Science and Technology   (China)

^d HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ALLELE; APAL GENE; ARTICLE; ASIAN; BSML GENE; CAUCASIAN; DISEASE PREDISPOSITION; FOKL GENE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PRIORITY JOURNAL; PSORIASIS; PUBLISHING; TAQL GENE;

DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PSORIASIS; RECEPTORS, CALCITRIOL; RISK;

EID: 84877634076     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04553.x     Document Type: Article

References (37)

1. Vanscott EJ, Ekel TM,. Kinetics of hyperplasia in psoriasis. Arch Dermatol 1963; 88: 373-381.
2. Fry L, McMinn RM,. Observations on mitosis in psoriatic epidermis. Br J Dermatol 1970; 82: 19-22.
3. Kragballe K, Gjertsen BT, De Hoop D, et al. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-196.
4. Smith EL, Walworth NC, Holick MF,. Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-714.
5. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
6. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
7. Dayangac-Erden D, Karaduman A, Erdem-Yurter H,. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res 2007; 299: 487-491.
8. Tiala I, Suomela S, Huuhtanen J, et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med 2007; 85: 589-601.
9. Kittaka A, Saito N, Takano M,. Recent progress of study on vitamin D analogs. Clin Calcium 2006; 16: 1154-1165.
10. Wolters M,. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol 2005; 153: 706-714.
11. Halsall JA, Osborne JE, Pringle JH, et al. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics 2005; 15: 349-355.
12. Perakyla M, Malinen M, Herzig KH, et al. Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol Endocrinol 2005; 19: 2060-2073.
13. Lu J, Goldstein KM, Chen P, et al. Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J Invest Dermatol 2005; 124: 778-785.
14. Giomi B, Ruggiero M, Fabbri P, et al. Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?. J Dermatol Sci 2005; 37: 180-181.
15. Ruggiero M, Gulisano M, Peruzzi B, et al. Vitamin D receptor gene polymorphism is not associated with psoriasis in the Italian Caucasian population. J Dermatol Sci 2004; 35: 68-70.
16. Saeki H, Asano N, Tsunemi Y, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci 2002; 30: 167-171.
17. Kaya TI, Erdal ME, Tursen U, et al. Association between vitamin D receptor gene polymorphism and psoriasis among the Turkish population. Arch Dermatol Res 2002; 294: 286-289.
18. Okita H, Ohtsuka T, Yamakage A, et al. Polymorphism of the vitamin D(3) receptor in patients with psoriasis. Arch Dermatol Res 2002; 294: 159-162.
19. Lee DY, Park BS, Choi KH, et al. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients. Arch Dermatol Res 2002; 294: 1-5.
20. Fujishima T, Konno K, Nakagawa K, et al. Synthesis and biological evaluation of all A-ring stereoisomers of 5,6-trans-2-methyl-1,25- dihydroxyvitamin D(3) and their 20-epimers: possible binding modes of potent A-ring analogues to vitamin D receptor. Chem Biol 2001; 8: 1011-1024.
21. Zmuda JM, Cauley JA, Ferrell RE,. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22: 203-217.
22. Boehm MF, Fitzgerald P, Zou A, et al. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem Biol 1999; 6: 265-275.
23. Park BS, Park JS, Lee DY, et al. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 1999; 112: 113-116.
24. Mee JB, Cork MJ,. Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis. J Invest Dermatol 1998; 110: 301-302.
25. Kontula K, Valimaki S, Kainulainen K, et al. Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. Br J Dermatol 1997; 136: 977-978.
26. Michel G, Gailis A, Jarzebska-Deussen B, et al. 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells. Inflamm Res 1997; 46: 32-34.
27. Carlberg C, Saurat JH,. Vitamin D-retinoid association: molecular basis and clinical applications. J Investig Dermatol Symp Proc 1996; 1: 82-86.
28. Kragballe K,. Calcipotriol: a new drug for topical psoriasis treatment. Pharmacol Toxicol 1995; 77: 241-246.
29. Binderup L, Bramm E,. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889-895.
30. Rucevic I, Stefanic M, Tokic S, et al. Lack of association of vitamin D receptor gene 3'-haplotypes with psoriasis in Croatian patients. J Dermatol 2012; 39: 58-62.
31. Zuel-Fakkar NM, Kamel MM, Asaad MK, et al. A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis. Clin Exp Dermatol 2011; 36: 355-359.
32. Zhu HQ, Xie KC, Chen LD, et al. The Association between vitamin D receptor polymorphism and psoriasis. Chin J Dermatol 2002; 35: 386-388.
33. Viitanen A, Karkkainen M, Laitinen K, et al. Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young finns. Calcif Tissue Int 1996; 59: 231-234.
34. Xu J, Turner A, Little J, et al. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error?. Hum Genet 2002; 111: 573-574.
35. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
36. Carling T, Rastad J, Akerstrom G, et al. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998; 83: 2255-2259.
37. Beaumont M, Bennett AJ, White DA, et al. Allelic differences in the 3' untranslated region of the vitamin D receptor gene affect mRNA levels in bone cells. Osteoporos Int 1998; 8: 37.